相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal et al.
HEPATOLOGY (2022)
Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients With Cirrhosis
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Serum Levels of α-Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma
David M. Hughes et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma
Naga P. Chalasani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
Johann von Felden et al.
ONCOGENE (2021)
We need stronger evidence for (or against) hepatocellular carcinoma surveillance
Peter Jepsen et al.
JOURNAL OF HEPATOLOGY (2021)
Liquid biopsy enters the clinic - implementation issues and future challenges
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
NGS-based accurate and efficient detection of circulating cell-free mitochondrial DNA in cancer patients
Yang Liu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
Andrew X. Zhu et al.
BRITISH JOURNAL OF CANCER (2021)
Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients
Lei Chen et al.
CELL RESEARCH (2021)
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands
Joshua D. Cohen et al.
NATURE BIOTECHNOLOGY (2021)
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Y. M. Dennis Lo et al.
SCIENCE (2021)
A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Matthew H. Larson et al.
NATURE COMMUNICATIONS (2021)
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
Karim J. Halazun et al.
JAMA SURGERY (2021)
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
Nia Adeniji et al.
HEPATOLOGY COMMUNICATIONS (2021)
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer
Wei Chen et al.
HEPATOLOGY INTERNATIONAL (2020)
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial
Masatoshi Kudo et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis
Georgia Zeng et al.
GUT (2020)
Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer
Chiao-Ling Li et al.
HEPATOLOGY (2020)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon et al.
SCIENCE (2020)
Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
Jian Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing
Haikun Zhang et al.
BMC MEDICINE (2020)
Current status of development of methylation biomarkers for in vitro diagnostic IVD applications
Olga Taryma-Lesniak et al.
CLINICAL EPIGENETICS (2020)
Bioactive DNA from extracellular vesicles and particles
Ethan Z. Malkin et al.
CELL DEATH & DISEASE (2020)
Next generation sequencing-based analysis of mitochondrial DNA characteristics in plasma extracellular vesicles of patients with hepatocellular carcinoma
Yijie Li et al.
ONCOLOGY LETTERS (2020)
Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
Na Sun et al.
NATURE COMMUNICATIONS (2020)
NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis
C. Yin et al.
ANNALS OF ONCOLOGY (2019)
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
Chunfeng Qu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
Chung Ryul Oh et al.
BMC CANCER (2019)
Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma
Chang Tan et al.
CLINICAL CHEMISTRY (2019)
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G. Rothwell et al.
NATURE MEDICINE (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
Zhixiong Cai et al.
CLINICAL CANCER RESEARCH (2019)
Topologic Analysis of Plasma Mitochondrial DNA Reveals the Coexistence of Both Linear and Circular Molecules
Mary-Jane L. Ma et al.
CLINICAL CHEMISTRY (2019)
Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
Jiabin Cai et al.
GUT (2019)
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
Yu Jin et al.
SCIENTIFIC REPORTS (2019)
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
Mark Yarchoan et al.
CANCER RESEARCH (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Pedram Razavi et al.
NATURE MEDICINE (2019)
Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis
Dahai Xu et al.
ANNALS OF HEPATOLOGY (2019)
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score
Ju Dong Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis
Nabihah Tayob et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: a pilot study
C. K. Y. Ng et al.
ANNALS OF ONCOLOGY (2018)
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
Ho Yeong Lim et al.
CLINICAL CANCER RESEARCH (2018)
Why Won't the Alpha-fetoprotein Test Go Gentle Into the Good Night?
Samuel S. Lee et al.
GASTROENTEROLOGY (2018)
Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma
Min Shi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics
Sadakatsu Ikeda et al.
MOLECULAR CANCER THERAPEUTICS (2018)
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Ismail Labgaa et al.
ONCOGENE (2018)
Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
Sadakatsu Ikeda et al.
ONCOLOGIST (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Vogel et al.
ANNALS OF ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Testing for AFP in combination with ultrasound improves early liver cancer detection
Kristina Tzartzeva et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen et al.
NATURE (2018)
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
O. Simmons et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey
Hienori Toyoda et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K. C. Allen Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis
Zhen Qu et al.
ONCOTARGET (2017)
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
Chun-Xiao Song et al.
CELL RESEARCH (2017)
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
Wenshuai Li et al.
CELL RESEARCH (2017)
Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC
Mengjun Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma
Mengjun Wang et al.
CANCER PREVENTION RESEARCH (2016)
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection
Gian Paolo Caviglia et al.
HEPATOLOGY RESEARCH (2016)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma
J. Best et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2016)
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill et al.
PLOS GENETICS (2016)
Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
Ling Li et al.
SCIENTIFIC REPORTS (2016)
Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation
K. Sugimachi et al.
BRITISH JOURNAL OF CANCER (2015)
Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients (vol 25, pg 1250, 2015)
Lu Wen et al.
CELL RESEARCH (2015)
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2015)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
R. Fox et al.
BRITISH JOURNAL OF CANCER (2014)
The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers
Philip J. Johnson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer
Florent Mouliere et al.
MOLECULAR ONCOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Maxime Ronot et al.
ONCOLOGIST (2014)
Diagnostic Performance of Des-gamma-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
Rong Zhu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2014)
Alpha-fetoprotein-L3 in hepatocellular carcinoma: A meta-analysis
Xiaoyan Yi et al.
CLINICA CHIMICA ACTA (2013)
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2013)
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Verena Koeberle et al.
EUROPEAN JOURNAL OF CANCER (2013)
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Zhengyan Kan et al.
GENOME RESEARCH (2013)
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
Cheng Xu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K. C. Allen Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
Pierre-Alain Clavien et al.
LANCET ONCOLOGY (2012)
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Wing-Kin Sung et al.
NATURE GENETICS (2012)
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
Shaheed Merani et al.
JOURNAL OF HEPATOLOGY (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Liver Cancer Working Group Report
Masatoshi Kudo et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Serological Surveillance for hepatocellular carcinoma: Time to quit
M. Sherman
JOURNAL OF HEPATOLOGY (2010)
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
A. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
Tony K. F. Yung et al.
CLINICAL CANCER RESEARCH (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
α-Fetoprotein for Hepatocellular Carcinoma Diagnosis: The Demise of a Brilliant Star
Alejandro Forner et al.
GASTROENTEROLOGY (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers
Hidenori Toyoda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Relationship between Lens culinaris agglutinin-reactive α-fetoprotein and pathologic features of hepatocellular carcinoma
T Tada et al.
LIVER INTERNATIONAL (2005)
High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection
K Ohata et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Biological roles of alpha-fetoprotein during pregnancy and perinatal development
GJ Mizejewski
EXPERIMENTAL BIOLOGY AND MEDICINE (2004)
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
SB Baylin et al.
HUMAN MOLECULAR GENETICS (2001)
Presence of mitochondrial tRNA Leu(UUR) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus
S Zhong et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
分享论文
